Dec 15, 2022 / 01:30PM GMT
Operator
Good day, and welcome to the BioCryst conference call. (Operator Instructions) Please note today's event is being recorded. I would now like to turn the conference over to John Bluth at BioCryst. Please go ahead.
John D. Bluth - BioCryst Pharmaceuticals, Inc. - Chief Communications Officer
Thank you. Good morning, and thanks for joining our call this morning. A press release issued earlier today is available on our website and participating with me today on the conference call are CEO, Jon Stonehouse; CFO, Anthony Doyle; Chief Commercial Officer, Charlie Gayer; Chief R&D Officer, Dr. Helen Thackary; Chief Medical Officer, Dr. Ryan Arnold; and Chief Development Officer, Dr. Bill Sheridan. Following our remarks, we'll answer your questions.
Before we begin, please note that today's conference call will contain forward-looking statements, including those statements regarding future results, unaudited and forward-looking financial information as well as the company's future performance and/or achievements. These statements are subject to unknown risks
BioCryst Pharmaceuticals Inc Conference Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot